INTRODUCTION
Hepatitis A virus (HAV) is endemic in many developing countries, where the prevalence can approach 100% in children by 5 years of age [2] . It is responsible for all 75% of viral hepatitis in the world. The disease has global distribution and is more common in areas with low levels of socioeconomic development. Incidence is elevated in developing countries and the majority of these populations will become infected before the age of 10 years [3] .
The seroprevalence of HAV is low in developed countries and the greater part of those populations will remain susceptible to infection even at advanced ages [4] . Persons infected shed HAV in their feces 7-10 weeks before the onset of clinical symptoms. HAV concentration in feces is highest during the prodromal phase. For those who develop symptoms, the concentration is usually very low by the time jaundice appears and undetectable before symptoms abate [4] .
Epidemiologically, predictors of HAV infection include poor household condition, low socioeconomic status, residence in rural community, poor and inadequate water sources, and limited access to environmental sanitation facilities [5] . Several additional high-risk population groups have been identified, including those who travel or emigrate from a non-endemic region to an endemic region and those who work in certain high-risk occupations, such as some daycare employees [6] .
The disease spreads most quickly in highly populated areas with poor sanitation infrastructure and a shortage of water. Infections occur most commonly among children under the age of ten, and in most cases, the patients remain asymptomatic [7] . In most of the developed world, HAV is more likely to be contracted by older adolescents or adults [7] . In some cases, HAV infection has significantly increased the age at contraction. Delay in HAV exposure has made large population of adolescents and adults susceptible and of high risk of HAV and could lead to outbreaks of hepatitis A [8] . In view of this, it's important to consider implementing vaccination programs that target to certain populations at higher risk of infection [9] .
There is paucity of data on the prevalence of HAV in Sokoto State, North Western Nigeria. This prospective cross-sectional study was designed to determine the seroprevalence and risk factors of HAV among blood donors in three tertiary Hospitals in Sokoto State, Nigeria.
MATERIALS AND METHODS

Study design and Site
This cross-sectional study was carried on one hundred and sixty eight (168) Sample Collection 3 mL of blood sample was collected from individual participant using standard venipuncture phlebotomy. The sample was carefully and gently dispensed into a sterile plain sample container. The tubes were labelled appropriately with participants' identification number.
Sera from the blood samples were separated by allowing the blood to clot at room temperature then by centrifugation at 2500rpm for 10 minutes. Thereafter transferred into serum aliquot container and stored at -20'C pending laboratory analysis.
Serum HAV Enzyme Linked Immunosorbent Assay (IgM and IgG ELISA)
The serum samples were tested for the presence of HAV-IgM level using the sandwich Enzyme Linked Immunosorbent Assay (ELISA) kit produced by Melsin Medical Co., Limited. Jilin Province, China. The Melsin HAV-IgM and IgG ELISA kits have Assay sensitivity of 99.75% and Specificity of 99.9%. Analyses were done based on kits manufacture's instruction.
HAV-IgM and IgG ELISA are solid phase, twostep incubation, antibody capture ELISA assay in which, polystyrene microwell strips are precoated with antibodies directed to IgM and IgG proteins (anti-ì chain). The subjects' sera were added. During the 1st incubation, any antibodies will be captured in the wells. After washing out all the other components of the sample, the specific HAV antibody will be captured on the solid phase, and was detected by the addition of HAV antigens conjugated to horseradish peroxidise (HRP-Conjugate). During the second incubation, the HRP-conjugated antigens will specifically react only with the HAV antibodies. After washing to remove unbound HRP-conjugate, a tetramethylbenzidine (TMB) chromogen solution was added to the wells. In presence of the (anti-ì)-(HAVantibody)-(antigen-HRP) immunocomplex, the colorless Chromogens were hydrolyzed by the bound HRP conjugate to a blue-colored product. The blue color turns yellow after stopping the reaction with sulfuric acid. The amount of color intensity can be measured and is proportional to the amount of antibody captured in the wells, and to the sample respectively. Wells containing samples negative for HAV-antibodies remain colorless.
Sample size
The sample size was determined using prevalence rate demonstrated by Ramezani et al [10] . This was 150. Hence the minimum calculated sample size was N = 150
Attrition rate= (150X0.2)= 30. N= 30 +150= 180
Data collection
Questionnaires were used to collect sociodemographic data, such as gender, age, marital status, occupation, number of Household members, availability of hygienic toilet facility and good water supply.
Sample collection 2 milliliters of blood sample was collected from individual participant using standard venepunture phlebotomy. The sample was carefully and gently dispense into a sterile plain sample container. The tube was labeled appropriately with participants' identification number. Sera from the blood samples were separated by allowing the blood to clot at room temperature then by centrifugation at 2500rpm for 10 minutes. Thereafter transferred into serum aliquot container and stored at -20'C pending laboratory analysis.
Statistical analysis
Data obtained from ELISA and questionnaire were presented in tabular and graphical forms. Pearson Chi square test at a 95% confidence interval and a significance level of 0.05 was used to determine the association between sociodemographic data and seroprevalence rates using Statistical Package for Social Sciences (SPSS version 23, California, USA).
RESULTS
One hundred and sixty-eight (168) Thus, anti-HAV IgG seropositivity was 86.3% and anti-HAV IgM seropositivity was 0.0% (Table 1) . Table 2a shows the distribution of HAV-specific IgG and IgM seropositivity across ages of blood donors. HAV IgG seropositivity was mostly observed among those age range (20-30) years; (31-40) years had 86.2% while above 41 years (76%). Table 3 shows the distribution of Human HAV-specific IgG seropositivity across occupation, number of household members, availability of good toilet facility, and availability of good water supply. There was no significant association between seroprevalence and any of the risk factors and sociodemographic variables studied (p>0.05). , who reported that prevalence of HAV infection is not the same in different parts of the world (varies between 15% and 100%), and depends on geographic area, sanitary levels and socioeconomic conditions. This disparity in prevalence could be due to difference in duration of study, the location of the study, level of hygiene, water supply, vaccination, endemicity of the virus, the study subjects and use of different test system with varying sensitivity.
There was an exponential decrease in prevalence HAV based on age distribution. 
CONCLUSION
Findings from this study indicated that a large number of the blood donors are already immune to HAV infection, while none of them had active HAV infection. The high prevalence of Hepatitis A antibodies among the studied subject reflects a high HAV transmission rate in this area. Hence, determination of HAV should be taken into consideration before blood transfusion.
Ethical Consideration and Informed Consent
Ethical approval was obtained from the Ethical and Human research committee of the Ministry of Health, Sokoto state. Informed consent was also obtained from all participating subjects in accordance with the standards of human experimentation and with the Helsinki Declaration of 1975, as revised in 2000. This was done via an informed consent forms duly completed by all the subjects.
